Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.
Androgen deprivation therapy (ADT) results in testosterone suppression, a hypothesized mechanism linking ADT to depressive symptoms. This study investigated the relationship between ADT and the risk of subsequently being diagnosed with depressive disorder (DD) during a 3-year follow-up period. The p...
Main Authors: | Shiu-Dong Chung, Li-Ting Kao, Herng-Ching Lin, Sudha Xirasagar, Chung-Chien Huang, Hsin-Chien Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5333913?pdf=render |
Similar Items
-
Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease.
by: Herng-Ching Lin, et al.
Published: (2017-01-01) -
Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.
by: Herng-Ching Lin, et al.
Published: (2017-01-01) -
Weekly and holiday-related patterns of panic attacks in panic disorder: a population-based study.
by: Li-Ting Kao, et al.
Published: (2014-01-01) -
Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
by: Kuang-Ming Liao, et al.
Published: (2019-12-01) -
Predictive clinical indicators of biochemical progression in advanced prostate cancer patients receiving Leuplin depot as androgen deprivation therapy.
by: Chien-Hua Chen, et al.
Published: (2014-01-01)